Table 4.
Among Young People with Long-Term and Short-Term Stimulant Use, Percentages with Stimulant Prescriptions from Selected Provider Groups, United States 2008
| Age (years) | ||||
|---|---|---|---|---|
| 3–5 (%) | 6–12 (%) | 13–18 (%) | 19–24 (%) | |
| Among youth with stimulant prescriptions | ||||
| With long-term stimulant use (≥120 days) | 35.7 | 55.8 | 52.2 | 43.0 |
| Among youth with long-term stimulant prescriptions | ||||
| Pediatricians, any | 49.5 | 52.9 | 42.6 | 14.5 |
| Nonpediatric primary care providers, any | 13.0 | 17.0 | 21.1 | 44.9 |
| Child and adolescent psychiatrists, any | 23.4 | 19.6 | 20.8 | 12.1 |
| Psychiatrists, any | 41.3 | 34.0 | 38.1 | 39.3 |
| Among youth with stimulant prescriptions | ||||
| With short-term stimulant use (≤30 days) | 33.1 | 21.6 | 23.0 | 29.5 |
| Among youth with short-term stimulant prescriptions | ||||
| Pediatricians, any | 42.9 | 46.2 | 35.5 | 10.5 |
| Nonpediatric primary care providers, any | 10.4 | 13.6 | 20.1 | 42.1 |
| Child and adolescent psychiatrists, any | 15.3 | 13.0 | 14.4 | 8.0 |
| Psychiatrists, any | 30.4 | 26.0 | 31.0 | 31.8 |
IMS LifeLink® Information Assets-LRx Longitudinal Prescription Database, 2008, IMS Health Incorporated. Long-term stimulant use defined as ≥120 days of supply during 2008. Short-term stimulant use defined as ≤30 days of supply during 2008.